Recommended Talks:

2nd Env Manufacturing Workshop
Choosing the right protein
September 2016
Hans Langedijk, Janssen, J&J
2nd Env Manufacturing Workshop
Case study of formulating protein for P5
September 2016
Antu Dey, International AIDS Vaccine Initiative (IAVI)
Product Development Boot Camp
Preclinical data and regulatory considerations
November 2015
Jim Ackland, Global Biosolutions
2nd Workshop on Prevention Trials in Infants Born to HIV-Positive Mothers
bNAbs development in infants
February 2017
Philip Goulder, Oxford University
No Monkey Business: Nonhuman Primate Models for HIV Prevention
October 2017
Co-Chair
Shelby O’Connor, University of Wisconsin
Matt Reynolds, University of Wisconsin
Introduction
Bargavi Thyagarajan, Global HIV Vaccine Enterprise
Non-human primate models of HIV maternal and infant immunization
Genevieve Fouda, Duke Human Vaccine Institute
Passive transfer of a single V2 monoclonal antibody reduces viral reservoirs in macaques during repeated SHIV challenges
Ann Hessell, Oregon Health & Science University
Tracking fluorophore-conjugated VRC01 following intravenous injection in the rhesus macaque
Jeffrey Schneider, Northwestern University
CyCMV vaccination induces unconventional CD8 T cells in mauritian cynomolgus macaques
Justin Greene, Oregon Health & Science University
Moderator
Shelby O’Connor, University of Wisconsin
Matt Reynolds, University of Wisconsin
Panelist
Genevieve Fouda, Duke Human Vaccine Institute
Ann Hessell, Oregon Health & Science University
Jeffrey Schneider, Northwestern University
Justin Greene, Oregon Health & Science University

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 1 day meeting   |   September 2016
The meeting reviewed the state of the field and latest advances in Env production, purification, and formulation. Webcasts | Learn More
Meeting Format: 1 day meeting   |   July 2016
Review the neut-sensitivity of Tiered virus panels and discuss the appropriate use of Tier-1A, -1B and -2 viruses for future vaccine development efforts. Webcasts | Learn More
Meeting Format: 1 day meeting   |   June 2016
Investigators generating and characterizing new SHIVs and clinical researchers using such challenge viruses convened to advance current research efforts. Webcasts
Meeting Format: 1 day meeting   |   April 2016
Various stakeholders share past experiences of innovative uses of technologies and discuss what could be adopted in future HIV clinical trials. Webcasts | Learn More
Meeting Format: 2 day meeting   |   November 2015
Presentations by product development experts, introduction to new resources, and active learning through discussion with peers and experts. Webcasts | Learn More
Meeting Format: 3 day meeting   |   October 2015
A webcast featuring several of the presentations of the 2015 Cent Gardes meeting, addressing a range of topics pertinent to HIV vaccine research. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2015
Immunologists and HIV vaccine experts review recent developments in germinal center (GC) biology and evaluate implications of defective GC physiology. Webcasts | Learn More
Meeting Format: 2 hour meeting   |   July 2015
An interactive session at IAS 2015 to explore the rapidly evolving HIV vaccine field, ranging from vaccine design to development and testing. Webcasts | Learn More
Meeting Format: 2 day meeting   |   June 2015
An exchange of information and experiences and a status update of ongoing efforts related to the GMP manufacturing of HIV ENV proteins. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   May 2015
A focus on immunogens design, novel immunization regimens, and tracking of antibody responses with the goal of eliciting broadly neutralizing antibodies. Webcasts | Learn More
1 2 3